Literature DB >> 20166932

Tyrosyl-DNA phosphodiesterase 1 targeting for modulation of camptothecin-based treatment.

G L Beretta1, G Cossa, L Gatti, F Zunino, P Perego.   

Abstract

The targeting of specific DNA repair mechanisms may be a promising strategy to improve the efficacy of antitumor therapy. The cytotoxic effects of the clinically relevant topoisomerase 1 (Top1) poison camptothecins are related to the generation of DNA lesions and tumor cells may be resistant to DNA damaging agents due to increased repair. Tyrosyl- DNA phosphodiesterase 1 (TDP1) is implicated in the repair of strand breaks by removing abortive Top1/DNA complexes. Thus, a role for TDP1 in counteracting DNA damage induced by camptothecins has been proposed. Here, we review the role of TDP1 in DNA repair with particular reference to TDP1 function, its cooperation with other pathways and the development of pharmacological inhibitors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20166932     DOI: 10.2174/092986710790979971

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  16 in total

1.  Identification of a ligand binding hot spot and structural motifs replicating aspects of tyrosyl-DNA phosphodiesterase I (TDP1) phosphoryl recognition by crystallographic fragment cocktail screening.

Authors:  George T Lountos; Xue Zhi Zhao; Evgeny Kiselev; Joseph E Tropea; Danielle Needle; Yves Pommier; Terrence R Burke; David S Waugh
Journal:  Nucleic Acids Res       Date:  2019-11-04       Impact factor: 16.971

2.  Synthesis, anti-cancer screening and tyrosyl-DNA phosphodiesterase 1 (Tdp1) inhibition activity of novel piperidinyl sulfamides.

Authors:  Jung Ho Jun; Vineet Kumar; Thomas S Dexheimer; Iwona Wedlich; Marc C Nicklaus; Yves Pommier; Sanjay V Malhotra
Journal:  Eur J Pharm Sci       Date:  2017-10-13       Impact factor: 4.384

3.  Synthesis and biological evaluation of indenoisoquinolines that inhibit both tyrosyl-DNA phosphodiesterase I (Tdp1) and topoisomerase I (Top1).

Authors:  Martin Conda-Sheridan; P V Narasimha Reddy; Andrew Morrell; Brooklyn T Cobb; Christophe Marchand; Keli Agama; Adel Chergui; Amélie Renaud; Andrew G Stephen; Lakshman K Bindu; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2012-12-21       Impact factor: 7.446

4.  5-Arylidenethioxothiazolidinones as inhibitors of tyrosyl-DNA phosphodiesterase I.

Authors:  Venkata Ramana Sirivolu; Sanjeev Kumar V Vernekar; Christophe Marchand; Alena Naumova; Adel Chergui; Amelie Renaud; Andrew G Stephen; Feng Chen; Yuk Y Sham; Yves Pommier; Zhengqiang Wang
Journal:  J Med Chem       Date:  2012-10-08       Impact factor: 7.446

5.  The influence of an enamine usnic acid derivative (a tyrosyl-DNA phosphodiesterase 1 inhibitor) on the therapeutic effect of topotecan against transplanted tumors in vivo.

Authors:  V P Nikolin; N A Popova; V I Kaledin; O A Luzina; A L Zakharenko; N F Salakhutdinov; O I Lavrik
Journal:  Clin Exp Metastasis       Date:  2021-08-09       Impact factor: 5.150

Review 6.  Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer.

Authors:  Ken-ichi Fujita; Yutaro Kubota; Hiroo Ishida; Yasutsuna Sasaki
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

7.  Common TDP1 Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer Consortium.

Authors:  Pawadee Lohavanichbutr; Lori C Sakoda; Christopher I Amos; Susanne M Arnold; David C Christiani; Michael P A Davies; John K Field; Eric B Haura; Rayjean J Hung; Takashi Kohno; Maria Teresa Landi; Geoffrey Liu; Yi Liu; Michael W Marcus; Grainne M O'Kane; Matthew B Schabath; Kouya Shiraishi; Stacey A Slone; Adonina Tardón; Ping Yang; Kazushi Yoshida; Ruyang Zhang; Xuchen Zong; Gary E Goodman; Noel S Weiss; Chu Chen
Journal:  Clin Cancer Res       Date:  2017-10-03       Impact factor: 12.531

8.  Structure Modeling of Human Tyrosyl-DNA Phosphodiesterase 1 and Screening for Its Inhibitors.

Authors:  I V Gushchina; D K Nilov; A L Zakharenko; O I Lavrik; V K Švedas
Journal:  Acta Naturae       Date:  2017 Apr-Jun       Impact factor: 1.845

9.  Novel Semisynthetic Derivatives of Bile Acids as Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibitors.

Authors:  Oksana V Salomatina; Irina I Popadyuk; Alexandra L Zakharenko; Olga D Zakharova; Dmitriy S Fadeev; Nina I Komarova; Jóhannes Reynisson; H John Arabshahi; Raina Chand; Konstantin P Volcho; Nariman F Salakhutdinov; Olga I Lavrik
Journal:  Molecules       Date:  2018-03-17       Impact factor: 4.411

10.  Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy.

Authors:  Apar Pataer; Ruping Shao; Arlene M Correa; Carmen Behrens; Jack A Roth; Ara A Vaporciyan; Ignacio I Wistuba; Stephen G Swisher
Journal:  Cancer Med       Date:  2018-04-19       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.